Military Grade Pain Relief is Now Available to Military Family Members

What’s lacking in the military healthcare system is the need for aggressive management of acute pain associated with combat injuries and trauma. Chronic pain in military community is widespread without any real solution in hand. Relivra strives to improve pain management in military and civilian medicine through continuous research and to bring products to the market which could positively improve the lives of active duty personnel, veterans and their families. Military personnel often experience substantial pain, which must be addressed before returning to active duty or civilian life.

The United States military has instituted several guidelines and initiatives aimed at improving pain management. Our team have started our research to find a solution to treat soldiers in pain over 7 years ago. We have been working tirelessly to develop a product which would provide rapid pain relief to military personnel and veterans. After experimenting with many forms of delivery mechanism: pills, tablets, injectables and devices, we have decided to use a cream with a breakthrough transdermal delivery mechanism where active ingredients get delivered straight to the source of pain as opposed to the existing pain creams on the market which gets stock in the upper layers of the skin without much effect. The result of this multi-year multi-agency research has been a breakthrough compound LN127Y which has undergone clinical trials and gained FDA registration under name Relivra. At last, military medics now have a solution to treat pain.

Stage I clinical trials has been completed in August , 2019. Results of this Stage of the trials indicated that Relivra significantly reduces pain, delivers effective pain relief with a favorable safety profile as its systemic absorption and bioavailability is 100% due to proprietary transdermal delivery method compared to average 6% of the systemic exposure from competing topical analgesics. Expert combination of low dose proprietary combination of APIs and Trans-botanicals Anesthetics/ Analgesics (Essential Oils, Flavonoids, Terpenoids, Alkaloids) powered by proprietary transdermal technology augment pain or potentiate pain relieve effect. Results of the 1st Stage of the Trial show Relivra as a highly effective transdermal analgesic and far superior to comparable topicals available on the market.

Relivra is currently a go-to pain relief product amongst military personnel and veterans. 

Realizing dare need of quality pain relief solutions, Relivra has made its blockbuster pain relief cream available to the families of active military personnel, members of reserve and veterans at www.Pain.army